Meet The New DG of NAFDAC, Prof. Moji Christianah Adeyeye

Prof Mojisola Adeyeye

It will be recalled that President Muhammadu Buhari appointedA�Prof. Moji Christianah Adeyeye on Nov 11, 2017 as substantive Director GeneralA�after 17 months of acting DG under the leadership of Mrs Yetunde Oni, who retired after attaining the age of 60 years.

Prof.A� Moji Christianah Adeyeye officially resume office at theA�NAFDAC corporate headquarters, Abuja on Thursday, November 30, 2017.

Below is part one of the rich bio data of Prof.A� Moji Christianah Adeyeye:

  1. Fellow, Nigerian Academy of Science
  2. Academic Research Fellow, American Association of Colleges of Pharmacy (AACP)
  3. J. William Fulbright Senior Specialist, Obafemi Awolowo, University, Ile-Ife, Nigeria
  4. First African Woman Fellow, American Association of Pharmaceutical Scientists (AAPS) – Only 3% of academia receives such recognition internationally
  5. J. William Fulbright Scholar Award for African Regional Research Program on AIDS and AIDS-Related Research, University of Lagos, Idi-Araba, Lagos and National Institute for Pharmaceutical Research and Development (NIPRD), Idu, FCT, Nigeria
  6. Expert in drug development, translational research and regulatory science
  7. Expert in pediatric HIV/AIDS pharmaceutical products and clinical trials
  8. Organizer and presenter at meetings; and delivered seminars on drug shortage and role of non-active ingredients in pharmaceutical products to international audience (including FDA and pharmaceutical companies) at AAPS conferences
  9. Author of 60 peer-reviewed research articles, 8 book/book chapters, and books
  10. Inventor and author of 6 patents
  11. Presenter of over 150 research and scholarly work at national and international meetings
  12. Supervisor of 12 MS and 7 PhD students
  13. Co-advisor of 18 graduate students as research committee member 14. Innovator in new programA�A� developmentA�A�A� a��A�A�A�A�A� built Biopharmaceutical SciencesA�A� departmentA�A�A�A�A�A� atA�A�A�A� Roosevelt University CollegeA�A�A�A� ofA�A�A�A�A�A�A� Pharmacy (RUCOP),A�A�A�A�A�A� hiredA� faculty, builtA�A� researchA�A� laboratories,A�A�A�A�A�A�A� procuredA� equipment to enhance the capacityA�A� ofA�A�A�A� theA�A� facultyA�A�A�A�A�A�A� membersA� andA� engage community stakeholdersA�A�A�A�A�A� (pharmaceuticalA�A�A�A�A�A�A� andA� biotechnologyA� companies) as advisoryA�A�A�A� board,A�A�A�A�A� collaboratorsA�A�A�A�A�A�A� andA� studentA�A�A�A� mentorsA�A�A�
  14. Successfully directed FDA, Nigeriaa��s NAFDAC andA� NHREC-approvedA� PhaseA�A�A�A�A�A� IA�A�A�A�A�A� clinicalA�A�A�A� trial (Bioequivalence)A�A�A�A�A�A� of pediatricA�A�A�A�A�A�A� ARV drugsA�A�A�A�A�A�A� atA�A�A�A� BaptistA�A�A�A� MedicalA�A�A� Center, OgbomosoA�A� (nowA�A�A�A�A�A�A� BowenA�A�A�A� University TeachingA� Hospital)A�
  15. Created Research Advisory Council at RUCOP to facilitate collaboration with the pharmaceutical industry in teaching, research and student mentoring

Education

Institution/LocationA�A�A�A�A� A�A�A�A�A�A�A�A�A�A�A�A�A�A�A�A�A�A�A� A�A�A�A�A�A�A� Degree A�A�A� A�A�A�A�A�A�A� Year

University of Nigeria, Nsukka,A� A� A� A� A� A� A� A� A� A�B. Pharm A�A�A�A�A�A�A� 1976

NigeriaA�A�A�

Pharmaceutics, University of Georgia, A�A�A�A� M.SA� A�A�A�A�A�A�A�A�A�A�A�A�A�A�A� 1985

Athens, GA, USAA� A� A� A� A� A� A� A� A� A� A� A� A� A� A� A� A� A� A� A�Pharmaceutics

University of Georgia, Athens, GA, USAA� A�PhDA� A�A�A�A�A�A�A�A�A�A�A�A�A� 1988

Academic And Administrative

2014 – 2017 Faculty Trustee, Roosevelt University – Board

2010 – 2018 Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation, College of Pharmacy, Roosevelt University, Schaumburg, IL

2010 – 2017 Chair, Department of Biopharmaceutical Sciences, College of Pharmacy, Roosevelt University, Schaumburg, IL

2003a��2010 Professor of Pharmaceutics and Pharmaceutical Technology, Division of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA, USA

2009 – A�A�Visiting Professor, Nnamdi Azikwe University, Awka, Anambra State, Nigeria

  • Delivered lectures to professional pharmacy students in Formulation and Development
  • Assessed studentsa�� learning through formative and summative mechanisms and grading
  • Presented seminars in Drug Development and Careers in Pharmacy 2009 – 2010 Chair, American Association of Pharmaceutical Scientists (AAPS) Membership Strategic Oversight Committee (MSOC) 2009 – Fulbright Specialist Visiting Scholar (Global/Public Health) Obafemi Awolowo University, Nigeria,
  • Taught Formulation and Development and Pharmaceutical Manufacturing to professional pharmacy students
  • Presented seminars in Drug Development and Careers in Pharmacy) 2006- Adjunct Professor, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria 2004-2005 Senior Fulbright Scholar, Faculty of Pharmacy, University of Lagos, Idi-Araba, Lagos and National Institute for Pharmaceutical Research and Development, Abuja, FCT
  • Conducted research on Quality Assurance and Bioequivalence of Anti-retroviral Drugs for Treatment of HIV/AIDS
  • Taught Formulation and Development and Pharmaceutical Manufacturing; Assessment of learning through exams and grading; Presentation of seminars in Drug Development)

2004 – President, Drugs for AIDS and HIV Patients (DAHP) a�� a faith based tax-exempt organization. USA)A�A�

Project: Prevention of HIV/AIDS Among Nigerian YouthsA�A�A� Prevention of Mother-to-child Transmission and Care for Orphans and Vulnerable Children in Lagos, Osun and Oyo States

1999-2004 President, Nigerian Association of American Pharmaceutical Scientists

1994 -2003 Associate Professor of Pharmaceutics, Duquesne Pittsburgh, PA, USAA�A�A�A�A�

1989 a�� 1994 Assistant Professor, Duquesne University, Pittsburgh, PAA� 1988 a�� 1989 Assistant Professor, School of Pharmacy, University of Puerto Rico, San Juan, Puerto RicoA�A�A�A�A�A�A�A�

1979 – 1980 Head of Pharmacy, Baptist Hospital, Ogbomoso, Oyo State, Nigeria

1976 – 1979 Pharmacist, University College Hospital, Ibadan, Oyo State, Nigeria

Consultancy

  • Expert Witness in Pharmaceutical Products litigations
  • Opinions on the Pharmaceutical Science of Products under Litigation
  • Investigative Pharmaceutical Development and Analysis
  • Pre-Court Trial Deposition

Awards And Honors

2016 Fellow, Nigerian Academy of Science

2015 Academic Research Fellow, American Association of Colleges of Pharmacy (AACP)A�

2013 Recognition Award in Community Partnership, Northwest Illinois Educational Council for Student Success (NECSS)

  • For significant contribution in the field career exploration and technology education of high school students

2011 Recognition Service Award, AAPS Manufacturing Science Engineering SectionA�

2009 J. William Fulbright Senior Specialist Candidate, Obafemi Awolowo University, Ile-Ife, Nigeria

2008 Fellow, American Association of Pharmaceutical Scientists (AAPS)A�A�

2008 Duquesne University Presidential Award for Excellence in Service to the Mission

2008 Award for Excellence in Service, School of Pharmacy, Duquesne University a�?

2006- J. William Fulbright Senior Specialist Candidate

2004-2005 J. William Fulbright Scholar Award for African Regional Research Program on AIDS and AIDS-Related Research

2003 Duquesne University Presidential Award for Excellence in ScholarshipA�

2001, 2003 Award for Excellence in Scholarship, School of Pharmacy, Duquesne UniversityA�

2003 Award for Excellence in Scholarship, Division of Pharmaceutical Sciences, Duquesne UniversityA�A�

1998 Recognition: Focus Group Member: Capsugel Expert System for Development of Hard Gelatin Capsule Dosage FormA�

1991/1992 Marquis Who is Who of American Women

1985/1986 Award for Excellence in Research Program by a Graduate student, School of Pharmacy, University of Georgia

1983 Graduate Fellowship, American Association of University Women (AAUW)A�

Instruction, Seminars And Research In Drug Product Quality Control, Regulatory Good Clinical Practice And Approval

Courses/Topics Taught To Graduate And Professional Students (1988 a�� Present)

  • Drug Delivery and Industrial Pharmacy
  • Dosage Formulation and Development (including solid state characterization of excipients, drug-excipient interaction), Modified Release Technology, Excipients, etc.
  • Pharmaceutical Manufacturing
  • FDA Current Good Manufacturing Practices,
  • Solid Dosage Forms (Tablets and Capsules) Development
  • Manufacturing and Role of Excipients
  • Safety of Excipients
  • Manufacturing Equipment Cleaning Validation
  • Pharmaceutical Site Inspection and Violation
  • Pharmaceutical Unit Processes a�� Processes used in Solids Development and Influence of Excipients on Manufacturability
  • Pharmaceutical Unit Processes – Processes used in Liquids (suspensions, emulsions and solutions)

Seminars (Organized and Taught)A�A�A�

  • 1994: Technomic Seminar Series:

Pharmaceutical Excipients: Towards the TwentyFirst Century, Meadowlands, New Jersey.A�A�A�

1995:A� Technomic Seminar Series:

Pharmaceutical Excipients: Towards the Twenty First Century, Basel, Switzerland.A�A�

  • 1997 a�� 2000: Duquesne University Pharmaceutical Seminar Series: Pharmaceutical Unit Processes and Solid Dosage Form Development: Industry and Regulatory Perspectives. PittsburghA�A�A�
  • 1998 a�� 2000: Duquesne University Pharmaceutical Seminar Series: Pharmaceutical Unit Processes and Liquids/Semisolids Solid Dosage Form Development: Industry and Regulatory Perspectives. PittsburghA�A� a�?2005:A� AAPS 19th Annual Meeting, Nashville, Tennessee, Preformulation and Pharmaceutical Product Development.A� Symposium Program Planning Committee and Chair.A�A�A�A�A�A�A�A�A�
  • 2007: AAPS 21st Annual Meeting, San Diego, November. Drug-Excipient Interaction and Characterization, Roundtable
  • 2012: AAPS 26th Annual Meeting, Chicago, Illinois, Overcoming Drug Shortages in the USA. Roundtable/Hot Topic. A�

2010: Organized And Co-Taught Good Clinical Practice

  • Presented part of the following 12 Modules by Clintriad Pharma Services, July 30 & 31 2010, Bowen University teaching Hospital (BUTH), Ogbomoso, Oyo State, Nigeria
  • Audience: medical doctors, nurses, social workers of BUTH
  • Ethical Issues in Clinical Research: Development of ICH GCPs
  • The Drug Development Process
  • Roles and Interactions of Key Players in Clinical Research
  • Trial Start-Up Process
  • Essential Documents and Subject records; Subject Recruitment and retention
  • Informed Consent Process; Site Visits
  • Study Coordinatora��s Responsibilities; Adverse Events and Safety Reporting
  • Institutional review Board
  • Readiness for Sponsora��s Audit and regulatory Inspections

Drug Product ApprovalA�

  • Investigational New Drug (IND) Application Submission To The FDA
  • Zidovudine, Lamivudine, Nevirapine Fixed dose and fast disintegrating tablets for suspension and granules for reconstitution. IND No. – 108,518. 2010
  • The IND was submitted in partnership with Elim Pediatric Pharmaceuticals Inc. The emphasis was on optimization of performance (disintegration and taste) of pediatric antiretrovirals drugs (using various excipients) for the treatment of HIV/AIDS
  • Phase I (Bioequivalence) Clinical Trial – ClinicalTrials.gov Identifier: NCT01469520
  • Submission of NDA (505.b.2) for product registration – In preparation Investigational New Drug (IND) Application Submission to the National Agency For Food and Drug Administration (NAFDAC), Nigeria
  • Zidovudine, Lamivudine, Nevirapine Fixed dose and Fast Disintegrating Tablets for Suspension and Granules for Reconstitution a�? Submitted in partnership with Elim Pediatric Pharmaceuticals Inc. July 2010
  • Phase I (Bioequivalence) Clinical Trial
  • Approval of Clinical Protocol – January 2014
  • Request to submit application for registration of imported drugs a�� May 2014

Supervised Graduate Students And Post-Doctoral Associates

  • Graduated 12 M.S. and 7 Ph.D. students
  • Co-advised 18 other students as research committee member

Careers Of Former Graduate Students (Examples)

  • Dr. Vinod Vilivalam a�� Director of Strategic Market and Technical Development, Americas, West Pharmaceutical Services Exton PA
  • Dr. Sherif Badawy – Fellow, Bristol-Myers Squibb, Greater New York City
  • Dr. Rajiv Janjikhel a�� Senior Director, Alliance Management, Business Development & Planning, Forest Laboratories, NY
  • Dr. Ashwin Jain – Principal Research Scientist. Pfizer Inc.
  • Dr. Nkem Chukwumezie – Director, Product Development, Epic Pharma, LLC
  • Dr. Lavinia Lewis – Associate Research Fellow, Pfizer Inc.
  • Dr. Shobhan Sabnis – Sr. Manager, Global Technology Services, Zoetis
  • Dr. Fred Esseku a�� Manager, Pharmaceutical Development, Catalent Pharma Solutions

Post-Doctoral Associates

  • Dr. Adenike Okunlola a�� Lecturer, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
  • Dr. Nicholas Obitte- Senior Lecturer, University of Nigeria, Nsukka, Nigeria
  • Dr. Oladapo Adetunji, Lecturer, University of Ibadan, Ibadan, Nigeria

Research And Scholarly Activities a�� Publications And Patents Research Expertise

  • Preformulation
  • Early Phase Solid and Liquid State Characterization
  • Drug and Excipient Characterization
  • Forced Degradation
  • Analytical and Bio-analytical Method Development
  • Drug Product Development – Solids, Liquids, Ophthalmics, Parenterals (Injections)
  • Pediatric Product Development
  • Manufacturing and Scale-up
  • Excipient Functionality, Technology and Safety
  • Stability and Compliance to International Standards
  • Translational Research and Clinical Trials
  • Herbal Supplement Formulation Development and Evaluation

Publications – Books, Book Chapters And Research ArticlesA�

Books/ Book Chapters

  1. Christianah Moji Adeyeye and Pui-Kai Li. Diclofenac Sodium (Non-steroidal antiinflammatory drug): in Analytical Profile of Drug Substances, (Ed. K. Florey] Academic Press, 19, 123-144 (1991). ISBN: 0-12-2608194
  2. Christianah Moji Adeyeye and Eugene Barabas, Polyvinylpyrrolidone (Povidone). Analytical Profiles of Drug Substances and Excipients, (Ed. H. Brittain) Academic Press, 22, 555 – 686 (1993) ISBN:A� 0-12-260822-4A�
  3. Eugene Barabas and Christianah Moji Adeyeye, Crospovidone, Analytical Profiles of Drug Substances and Excipients, (Ed. H. Brittain), Vol. 24, Academic Press (1996) ISBN:0-12260824-0 A�A�A�
  4. Moji Christianah Adeyeye, Use of Chiral Excipients in Enantiomeric Formulations in Chirality in Drug Design and Development. Eds: Indra Reddy and Reza Mehvar. Marcel Dekker Inc. Publisher (1996): ISBN:0-8247-5062-4.A�
  5. Preformulation in Solid Dosage Form Development, Eds. Moji Christianah Adeyeye and Harry G. Brittain. Informa Healthcare Publisher. 2008. ISBN: 9780824758097
  6. Drug-Excipient Interaction Occurrences During Solid Dosage Form Development in Preformulation in Solid Dosage Form Development, Eds. Moji Christianah Adeyeye and Harry G. Brittain. Informa Healthcare Publisher. 2008. ISBN: 9780824758097
  7. Adeyeye, Moji: Out of Mouths of Children and What Adults (Everyone) Should Know About HIV/AIDS. Book Craft Publisher, Ibadan, Nigeria. 2005: ISBN 978203056-2
  8. Hard Shell Capsules in Clinical Trials: In Pharmaceutical Dosage Forms: Capsules. Moji Christianah Adeyeye and Amusa Adebayo. L. Augsbuger and S. Hoag (eds.), Taylor and Francis Group, Boca Raton, FL. 2017. In Press.

Research ArticlesA�

  1. Christianah Moji Adeyeye and James C. Price. Effect of Dextrose Concentration in the Internal Aqueous Phase on Formation and Stability of W/O/W Multiple Emulsions. Drug Dev. Ind. Pharm., 16 (6): 1053-1071 (1990)
  2. Christianah Moji Adeyeye and James C. Price. Effect of Surfactant Concentration and Type on the Formation and Stability of W/O/W Multiple Emulsions: Microscopic and Conductometric Evaluations. Drug Development and Industrial Pharmacy, Drug Dev. Ind. Pharm. 17 (5), 725-736 (1991)
  3. Christianah Moji Adeyeye, and James C. Price, Development and Evaluation of Sustained Release Ibuprofen-Wax Microspheres: I Effect of Formulation Variables on the Physical Characteristics. Pharm. Res., 8 (11), 1377-1383 (1991)
  4. Vinod Vilivalam and Christianah Moji Adeyeye, Development and in vitro Dissolution of Diclofenac Microspheres and Tabletted (Wax) Microspheres. J. Microencapsulation, 2(4), 455-470 (1994)
  5. Christianah Moji Adeyeye and James C. Price. Development and Evaluation of Sustained Release Ibuprofen – ax Microspheres: II.A� In Vitro Dissolution Studies, Pharm.A� Res. 11(4), 575-579 1994A�
  6. Christianah Moji Adeyeye, Jenny M. Rowley, Donatus Madu, Mehran Javadi and Shobhan S. Sabnis, Evaluation of Crystallinity and Drug release Stability of Directly Compressed Theophylline-Hydrophilic Matrix Tablets Stored under Varied Moisture Conditions. Int. J. Pharm.116, 65-75 (1995)
  7. Sherif Farag Badawy, M. Mahmoud Ghorab and Christianah Moji Adeyeye, Characterization and Bioavailability of Danazol-hydroxypropyl-I?-cyclodextrin Coprecipitates. Int. J. Pharm., 45-54 (1996)
  8. Christianah Moji Adeyeye, Jennifer Lesher and Sherif Badawy, Hygroscopicity and Stability of Danazol-Cyclodextrin Inclusion Complexes. Int. J. Pharm. Advances, 1(4), 419-428, April 1996
  9. Christianah Moji Adeyeye, J. Douglas Bricker and Vinod Vilivalam and W. Smith, Acute Gastrointestinal Toxic Effects of Suspensions of Unencapsulated and Encapsulated Ibuprofen (Wax-Microspheres) in Rats. Pharm Res. 13(5), 784-793 (1996)
  10. Sherif I. Farag Badawy, Mandy Marshall, Mahmoud M. Ghorab and Christianah Moji Adeyeye, Evaluation of Sulfobutylether Derivatives of Cyclodextrins as Solubility and Dissolution Enhancers of Danazol: Drug Develop. Ind. Pharm, 22 (9 and 10), 959-966 (1996)
  11. Peter Wipf, Wenjie Li, Christianah Moji Adeyeye, James M. Rusnak and John Lazo, Synthesis of Chemoreversible Prodrugs of Ara-C with Variable Time-Release Profiles. Biological Evaluation of their Apoptotic Activity: Bioorganic and Medicinal ChemistryA�A� Vol. 4, No. 10, pp. 1585-1596 (1996)A�
  12. Sherif I. Farag Badawy, Mahmoud M. Ghorab and Christianah Moji Adeyeye, Bioavailability of Danazol-Hydroxypropyl -I?- Cyclodextrin Complex by Different Route of Administration: Int. J. Pharm. 145, 137-143 (1996)
  13. Christianah Moji Adeyeye and James C. Price, Dissolution Stability and Microscopic Evaluation of Aged Suspensions of Sustained Release Ibuprofen-Wax Microspheres. J. Microencapsulation, Vol. 14 (3) 357-377 (1997)
  14. Rajiv K. Janjikhel and Christianah Moji Adeyeye, Stereospecific Formulation and Characterization of Sustained Release Ibuprofen Microspheres: J. Microencapsulation, Vol 14 (4), 409-426 (1997)
  15. Hideki Ichikawa, Yoshinobu Fukumori and Christianah Moji Adeyeye, Design and Preparation of Prolonged Release Microcapsules Containing Diclofenac Sodium Applicable for Suspensions. Int. J. Pharm. 156, 39-48 (1997)
  16. Christianah Moji Adeyeye and Fen-Fang Chen, Stereoselective Disposition of Suspensions of Conventional and Wax-matrix Sustained Release (Wax) Microspheres of Ibuprofen in Rats: 12(14), Pharm. Res. (1997)
  17. Lavinia Lewis, R. Boni and Christianah Moji Adeyeye, Effect of Emulsifier Blend on the Characteristics of Sustained Release Diclofenac (Wax) Microspheres: 15(3) J. Microencapsulation 283-298 (1998)
  18. Lavinia Lewis, Christianah Moji Adeyeye and R. Boni. The Physical and Chemical Stability of Suspensions of Sustained Release Diclofenac (Wax) Microspheres: J. Microencapsulation 15(5), 555-567 (1998)
  19. Shobhan Sabnis and Christianah Moji Adeyeye, Controlled Release Hydrophilic Tablets for Individualized Theophylline Therapy, Drug Dev. Ind. Pharm 25(2), 187-196 (1998)
  20. Rajiv Janjikhel and Christianah Moji Adeyeye, Dissolution of Ibuprofen Enantiomers from Coprecipitates and Suspensions Containing Chiral Excipients. Drug Develop. and Technol. 4(1) 9-17 (1999)
  21. Rajiv Janjikhel and Christianah Moji Adeyeye, Stereoselective Disposition of Ibuprofen Enantiomer Sustained Release Microspheres in Rats. Part I:A� Bioavailability Considerations.A� Drug DeliveryA�A� 6(3), 153-162 (1999)A�
  22. Rajiv Janjikhel, J. Douglas Bricker, D. Borochovitz and Christianah Moji Adeyeye, Stereoselective Disposition of Ibuprofen Enantiomer Sustained release Microspheres in Rats. Part II: Acute Gastrointestinal Toxicity. Drug DeliveryA�A� 6(3), 163-170 (1999)A�
  23. Nkere Ebube, G. Owusu Ababio and Christianah Moji Adeyeye, Preformulation Studies and Characterization of the Physicochemical Properties of Polymers Using Artificial Neural Network. Int. J. Pharm. 196, 27-35, 2000
  24. Ashwinkumar Jain and Christianah Moji Adeyeye, Characterization of Various Substituted Sulfobutyl Ether-I?Cyclodextrin Inclusion Complexes, Int. J. Pharm 212, 177-186, 2001
  25. Mohamed Ghorab and Moji Christianah Adeyeye Enhancement of Ibuprofen Dissolution via Wet Granulation with I?-Cyclodextrin. Pharm. Develop. and Technology 6(3), 303-312 (2001)
  26. Mohamed Ghorab and Moji Christianah Adeyeye, Elucidation of Solution State Complexation in Wet-Granulated Oven-dried Ibuprofen and I?-Cyclodextrin: FT-IR and 1H-NMR Studies, Pharm. Develop. and Technology 6(3), 313-322 (2001)
  27. Hideki Ichikawa, Kazuhiro Fujioka, Christianah Moji Adeyeye and Yoshinobu Fukumori, Use of Ion-exchange Resins to Prepare 100 A�m-sized Microcapsules with Prolonged Drugrelease by the Wurster Process, Int. J. Pharm. 216, 767-76 (2001)
  28. Moji Christianah Adeyeye, Roller Compaction and Milling Pharmaceutical Unit Processes, American Pharm. Review. Part I. November/Winter 2000. Invited
  29. Beatrice Nkem Chukwumezie, Mark Wojcik, Paul Malak and Moji Christianah Adeyeye, Feasibility Studies in Spheronization and Scale-up of Ibuprofen Microparticulates Using the Rotor Disk Fluid-bed Technology. PharmSci. Tech. 2002; 3(1) Article 2, 1-13. http://www.aapspharmscitech.org
  30. Christianah Moji Adeyeye, Ashwinkumar Jain, Mohamed K. Ghorab and William J. Reilly, Viscoeleastic Evaluation of Hydrocortisone Topical creams Containing Microcrystalline Cellulose/Sodium Carboxymethyl Cellulose (AvicelA� CL-611) as Stabilizer. PharmSci. Tech. 2002; 3(2) Article 7, 1-10. http://www.aapspharmscitech.org
  31. Ashwinkumar Jain, Bruce Aungst and Moji Christianah Adeyeye, Development and Invivo Evaluation of Buccal Tablets Prepared Using Danazol-Sulfobutylether-I?-Cyclodextrin 7 (SBE 7) Complexes J. Pharm. Sci. 91(7): 1659-1668 (2002)
  32. Mohamed Ghorab and Moji Christianah Adeyeye, Enhanced bioavailability of ProcessInduced fast Dissolving Ibuprofen Co-granulated with I?-Cyclodextrin, J. Pharm. Sci., 92(8), 2003
  33. V. J. Bijlani, C. Anderson, C. M. Adeyeye and J. K. Drennen III, Use of Near-Infrared Spectroscopy to Monitor Blend Uniformity and Hardness of Roller Compacted Briquettes. V. J. Bijlani, C. Anderson, C. M. Adeyeye and J. K. Drennen III. NIR News, 14(6) 2003A�
  34. Beatrice Nkem Chukwumezie, Mark Wojcik, Paul Malak, Frank Da��Amico and Moji Christianah Adeyeye, Factorial Design in the Spheronization of Ibuprofen Microparticulates Using Rotor Disk Fluid-Bed Technology, Pharm. Development and Technol. Vol. 9(1), pp. 49-62, 2004
  35. John P. Gibbs, Moji Christianah Adeyeye, Ziping Yang and Danny D. Shen, Valproic Acid Uptake by Bovine Brain Microvessel Endothelial Cells: Role of Active Efflux Transport. Epilepsy Research, 58 (2004) pp. 53-66
  36. Adeyeye, MC; Mwangi, E.; Katondo, B.; Jain, A.; Ichikawa, H.; Fukumori, Y. Dissolution stability studies of suspensions of prolonged-release (ion-exchange resinates) diclofenac microcapsules prepared by Wurster process: 1. Eudragit-based formulation and possible drug-excipient interaction. Journal of Microencapsulation. Vol: 22 NO: 4, 333-342, 2005
  37. Adeyeye, MC; Mwangi, E., Fujioka, K; Ichikawa, H., Fukumori, Y., Suspensions of prolonged-release diclofenac-EudragitA� and ion-exchange resin microcapsules: II. Improved dissolution stability. II, Improved Dissolution Stability.A� Journal of Microencapsulation. Vol: 22 NO: 4, 343-353, 2005A�
  38. Vishal Bijlani, Domotiere Yuonayel, Sabitha Katpally, Beatrice Nkem Chukwumezie, and M. C. Adeyeye, Monitoring Ibuprofen Release from (Avicel-based) Multi-particulates: In-situ Fiber Optic Technique versus the HPLC Method. A Technical Note.A� AAPS PharmSciTech, 2007; 8 (3) Article 52 (http://www.aapspharmscitech.org)A�
  39. Mohamed K. Ghorab and Moji Christianah Adeyeye. High Shear Mixing Granulation of Ibuprofen and I?-Cyclodextrin: Effects of Process Variables on Ibuprofen Dissolution. AAPS PharmSciTech 2007; 8 (4) Article 84 (http://www.aapspharmscitech.org).
  40. Fredrick Esseku, Mark Lesher, Vishal Bijlani, Samantha Lai, Ewart Cole and Moji Adeyeye, The Effect of Overencapsulation on Disintegration and Dissolution Pharmaceutical Technology Volume 34, Issue 4, pp. 104-111, 2010A�
  41. A. Joshi, F. Esseku, L. Silva, C. Igwilo, D. Oqua, B. Kunle, O. Obodozie, U. Inyang and Moji C. Adeyeye, Post-marketing In-vitro/in-vivo Assessment of Fixed Dose Combination Products of First Line Antiretrovirals. J. Pharm. Sci, 99(6):2655-63, 2010
  42. Udaya K. Kotreka and Moji Christianah Adeyeye. Gastro-Retentive Floating Drug Delivery Systems: A Critical Review. Critical Reviews in Therapeutic Drug Carrier Systems, 28(1), 47-99, 2011
  43. Fredrick Esseku and Moji Christianah Adeyeye. Bacteria and pH-sensitive polysaccharidepolymer films for colon targeted delivery. Crit Rev Ther Drug Carrier Syst 2011; 28(5):395445.
  44. Frederick Esseku, Anjali Joshi and Moji Christianah Adeyeye, Paediatric HIV/AIDS Drug Formulation Development In Academic Institutions As A Cost Reduction Strategy. International Pharmacy Pharmaceutical Federation Journal, Vol 27, No. 3 December 2011
  45. Anjali Joshi and Moji Christianah Adeyeye, Reversed Phase LC-UV Method Development and Validation for Simultaneous Determination of Three Antiretroviral: Lamivudine, Zidovudine, Nevirapine and Possible Degradants in a Fixed Dose Pharmaceutical Product. Pharmaceutical Technology & Drug Research 2012 1: 4 (24 April 2012). http://www.hoajonline.com/jptdr/1/1/4A�
  46. Fredrick Esseku, Anjali Josh, Yemisi Oyegbile, Grace Edowhorhu, Daniel Gbadero, and Moji Adeyeye, A Randomized Phase I Bioequivalence Clinical Trial of a Pediatric FixedDose Combination Antiretroviral Reconstitutable Suspension in Healthy Adult Volunteers. Antiviral Therapy. 2012. doi: 10.3851/IMP2310. http://www.intmedpress.com/journals/avt/abstract.cfm?id=2310&pid=48
  47. Nicholas C Obitte , Lisa C Rohan Christianah M Adeyeye, Michael A ParniakA� andA� Charles O Esimone, The utility of self-emulsifying oil formulation to improve the poor solubility of the anti HIV drug CSIC. AIDS Research and Therapy 2013, 10:14 doi:10.1186/1742-6405-10-14.A�
  48. N. C. Obitte, L. C. Rohan, C. M. Adeyeye and C. O. Esimone, Optimized Arthemeterloaded Anhydrous Emulsion, British Journal of Pharmaceutical Research 4(1): 37-59, 2014
  49. Adenike Okunlola, Sarafadeen Amusa Adebayo and Moji Christianah Adeyeye, Solid State Characterization of Two Tropical Starches Modified by Pregelatinization and Acetylation: Potential as Excipients in Pharmaceutical Formulations. British Journal of Pharmaceutical Research, 5 (1): 2231-2919. 2014
  50. Joshi, A., Gbadero, D., Esseku, F., Adesanya, O. J. and Adeyeye, M. C. (2016), A randomized two-way crossover bioequivalence study in healthy adult volunteers of paediatric zidovudine/lamivudine/nevirapine fast-disintegrating fixed-dose combination tablet. J Pharm Pharmacol. doi:10.1111/jphp.12666
  51. Adenike Okunlola, Sarafadeen Amusa Adebayo and Moji Christianah Adeyeye. Design of Repaglinide Microspheres Using Novel Acetylated Starches of Bitter and Chinese Yams as Polymers. International Journal of Biological Macromolecules, Volume 94, Part A, January 2017, Pages 544a��553. http://dx.doi.org/10.1016/j.ijbiomac.2016.10.032
  52. Udaya K. Kotreka, Vicki L. Davis and Moji C. Adeyeye. Development of In Situ GelForming Estradiol Eye Drops Intended for The Prevention of Age-Related Cataracts: Part I: Formulation Development and Stability Evaluation. Accepted for Publication. PLOS ONE Journal 2017. PONE-D-16-45134R2. In Press

 

Facebook Comments
READ  Is Amnesty International Truly Anti-Nigeria?

Leave a Reply

Your email address will not be published. Required fields are marked *